| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.19 | 0.2 |